Effect of polygenic risk scores on depression in childhood trauma
Wouter J. Peyrot, Yuri Milaneschi, Abdel Abdellaoui, Patrick F. Sullivan, Jouke J. Hottenga, Dorret I. Boomsma, Brenda W. J. H. Penninx
  • Declaration of interest




Research on gene × environment interaction in major depressive disorder (MDD) has thus far primarily focused on candidate genes, although genetic effects are known to be polygenic.


To test whether the effect of polygenic risk scores on MDD is moderated by childhood trauma.


The study sample consisted of 1645 participants with a DSM-IV diagnosis of MDD and 340 screened controls from The Netherlands. Chronic or remitted episodes (severe MDD) were present in 956 participants. The occurrence of childhood trauma was assessed with the Childhood Trauma Interview and the polygenic risk scores were based on genome-wide meta-analysis results from the Psychiatric Genomics Consortium.


The polygenic risk scores and childhood trauma independently affected MDD risk, and evidence was found for interaction as departure from both multiplicativity and additivity, indicating that the effect of polygenic risk scores on depression is increased in the presence of childhood trauma. The interaction effects were similar in predicting all MDD risk and severe MDD risk, and explained a proportion of variation in MDD risk comparable to the polygenic risk scores themselves.


The interaction effect found between polygenic risk scores and childhood trauma implies that (1) studies on direct genetic effect on MDD gain power by focusing on individuals exposed to childhood trauma, and that (2) individuals with both high polygenic risk scores and exposure to childhood trauma are particularly at risk for developing MDD.


  • Funding

    The Netherlands Study of Depression and Anxiety (NESDA) was funded by the Netherlands Organization for Scientific Research (Geestkracht program grant 10-000-1002); the Center for Medical Systems Biology (CMSB, NWO Genomics), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL), VU University’s EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam, ENGAGE (HEALTH-F4-2007-201413). Genotyping was funded by the US National Institute of Mental Health (NIMH) (RC2MH089951) as part of the American Recovery and Reinvestment Act of 2009. The Psychiatric Genomics Consortium was funded by NIMH grants MH085520 and MH080403. A.A. and W.J.P. were supported by CSMB/Neuroscience Campus Amsterdam. Statistical analyses were partly carried out on the Genetic Cluster Computer (www.geneticcluster.org), which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003), the Dutch Brain Foundation, and the Department of Psychology and Education of the VU University Amsterdam.

View Full Text